Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 06, 2024

SELL
$75.49 - $124.16 $714,512 - $1.18 Million
-9,465 Reduced 50.54%
9,262 $1.15 Million
Q3 2023

Nov 06, 2023

SELL
$86.06 - $137.93 $2.08 Million - $3.33 Million
-24,169 Reduced 56.34%
18,727 $1.75 Million
Q2 2023

Jul 27, 2023

BUY
$112.47 - $130.98 $343,483 - $400,012
3,054 Added 7.67%
42,896 $5.51 Million
Q1 2023

Apr 20, 2023

SELL
$104.0 - $122.92 $349,752 - $413,379
-3,363 Reduced 7.78%
39,842 $4.63 Million
Q4 2022

Feb 09, 2023

BUY
$84.98 - $122.67 $3.12 Million - $4.51 Million
36,737 Added 567.98%
43,205 $4.89 Million
Q3 2022

Oct 19, 2022

SELL
$76.35 - $94.18 $2.86 Million - $3.52 Million
-37,411 Reduced 85.26%
6,468 $520,000
Q2 2022

Aug 03, 2022

BUY
$67.99 - $132.89 $2.71 Million - $5.3 Million
39,882 Added 997.8%
43,879 $3.27 Million
Q1 2022

May 11, 2022

BUY
$94.08 - $130.2 $313,098 - $433,305
3,328 Added 497.46%
3,997 $2.13 Million
Q4 2021

May 03, 2022

BUY
$129.87 - $162.82 $86,883 - $108,926
669 New
669 $359,000

Others Institutions Holding DXCM

About DEXCOM INC


  • Ticker DXCM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 386,257,984
  • Market Cap $31.1B
  • Description
  • DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...
More about DXCM
Track This Portfolio

Track Lgt Group Foundation Portfolio

Follow Lgt Group Foundation and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lgt Group Foundation, based on Form 13F filings with the SEC.

News

Stay updated on Lgt Group Foundation with notifications on news.